UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (1254) 1254
life sciences & biomedicine (1205) 1205
animals (1183) 1183
male (1045) 1045
humans (957) 957
female (559) 559
gastric inhibitory polypeptide - pharmacology (506) 506
rats (495) 495
endocrinology & metabolism (470) 470
adult (438) 438
insulin - metabolism (417) 417
insulin - blood (407) 407
gastric inhibitory polypeptide - blood (378) 378
insulin secretion (350) 350
blood glucose - metabolism (327) 327
abridged index medicus (318) 318
mice (302) 302
gastric inhibitory polypeptide - metabolism (298) 298
pharmacology & pharmacy (279) 279
glucose (271) 271
insulin (271) 271
glucose - pharmacology (268) 268
glucagon-like peptide 1 (245) 245
middle aged (240) 240
physiology (233) 233
glucagon (213) 213
diabetes (201) 201
dose-response relationship, drug (185) 185
gastric emptying - drug effects (182) 182
gastroenterology & hepatology (175) 175
peptides (171) 171
gastric inhibitory polypeptide (165) 165
type 2 diabetes (165) 165
glucagon - blood (159) 159
blood glucose - analysis (156) 156
physiological aspects (155) 155
hormones, hormone substitutes, and hormone antagonists (149) 149
peptide fragments - pharmacology (149) 149
diabetes mellitus, type 2 - drug therapy (146) 146
in vitro techniques (144) 144
dogs (143) 143
gip (137) 137
time factors (136) 136
islets of langerhans - metabolism (133) 133
gastric emptying (131) 131
rats, wistar (131) 131
endocrine system (129) 129
rats, sprague-dawley (129) 129
biochemistry & molecular biology (128) 128
dextrose (126) 126
research (125) 125
digestive, oral, and skin physiology (123) 123
glucose tolerance test (122) 122
peptides - pharmacology (121) 121
gastrointestinal hormones - pharmacology (120) 120
glucagon-like peptide 1 - metabolism (117) 117
glucagon - metabolism (115) 115
islets of langerhans - drug effects (115) 115
glucagon - pharmacology (112) 112
analysis (109) 109
aged (108) 108
glucose - metabolism (107) 107
gastric inhibitory polypeptide - physiology (106) 106
hypoglycemic agents - pharmacology (105) 105
obesity (105) 105
medicine & public health (104) 104
rodents (104) 104
glucagon-like peptide 1 - blood (103) 103
kinetics (100) 100
gastric mucosa - metabolism (98) 98
blood glucose - drug effects (97) 97
glucose-dependent insulinotropic polypeptide (96) 96
diabetes mellitus, type 2 - metabolism (95) 95
gastric mucosa - drug effects (94) 94
rats, inbred strains (92) 92
research article (91) 91
cell line (90) 90
hormones (90) 90
nitric oxide (90) 90
vasoactive intestinal peptide - pharmacology (90) 90
glp-1 (89) 89
mice, inbred c57bl (89) 89
hypoglycemic agents - therapeutic use (88) 88
electric stimulation (87) 87
glucose - administration & dosage (87) 87
incretin (87) 87
health aspects (86) 86
receptors, gastrointestinal hormone - metabolism (86) 86
gastrointestinal motility - drug effects (85) 85
cells, cultured (84) 84
administration, oral (83) 83
glucagon-like peptide-1 (83) 83
glucagon-like peptides (83) 83
polypeptides (83) 83
insulin resistance (81) 81
neurosciences (80) 80
diabetes mellitus (78) 78
glucose metabolism (77) 77
internal medicine (77) 77
neurosciences & neurology (77) 77
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1924) 1924
Japanese (13) 13
French (5) 5
Chinese (3) 3
German (3) 3
Russian (3) 3
Hungarian (2) 2
Italian (1) 1
Portuguese (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cell metabolism, ISSN 1550-4131, 06/2013, Volume 17, Issue 6, pp. 819 - 837
... through neuronal and endocrine pathways. Here we contrast the pharmacology and physiology of incretin hormones and review recent advances in mechanisms coupling incretin receptor signaling to pleiotropic metabolic actions in preclinical studies... 
Endocrinology & Metabolism | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Animals | Gastric Inhibitory Polypeptide - metabolism | Glucagon-Like Peptide 1 - metabolism | Signal Transduction | Islets of Langerhans - metabolism | Humans | Incretins - metabolism | Mice | Receptors, Gastrointestinal Hormone - metabolism | Glucagon-Like Peptide 1 - secretion | Gastric Inhibitory Polypeptide - secretion | Body weight | Physiological aspects | Pharmacology | Diabetes | Glucose | Hormones | Dextrose | Index Medicus
Journal Article
The journal of clinical endocrinology and metabolism, ISSN 1945-7197, 11/2014, Volume 99, Issue 11, pp. E2325 - E2329
Journal Article
Diabetes (New York, N.Y.), ISSN 1939-327X, 11/2004, Volume 53, Issue Supplement 3, pp. S190 - S196
Journal Article
Diabetes, obesity & metabolism, ISSN 1462-8902, 01/2018, Volume 20, Issue 1, pp. 60 - 68
Aim To investigate the effects of the novel glucose‐dependent insulinotropic polypeptide (GIP... 
glycaemic control | GLP‐1 | diabetes | HbA1c | obesity | GIP | GLP-1 | Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Anti-Obesity Agents - blood | Gastric Inhibitory Polypeptide - pharmacokinetics | Obesity - drug therapy | Gastric Inhibitory Polypeptide - therapeutic use | Humans | Half-Life | Male | Diabetes Mellitus, Type 2 - metabolism | Weight Loss - drug effects | Receptors, Gastrointestinal Hormone - metabolism | Obesity - blood | Receptors, Gastrointestinal Hormone - agonists | Anti-Obesity Agents - therapeutic use | Glucagon-Like Peptide-1 Receptor - genetics | Hypoglycemic Agents - blood | Glucagon-Like Peptide-1 Receptor - metabolism | Anti-Obesity Agents - pharmacokinetics | Liraglutide - pharmacology | Mice, Mutant Strains | Drug Design | HEK293 Cells | Incretins - pharmacology | Drug Therapy, Combination | Gastric Inhibitory Polypeptide - pharmacology | Hypoglycemic Agents - therapeutic use | Receptors, Glucagon - genetics | Recombinant Proteins - metabolism | Hyperglycemia - prevention & control | Hypoglycemic Agents - pharmacokinetics | Mice, Inbred C57BL | Receptors, Glucagon - metabolism | Recombinant Proteins - chemistry | Recombinant Proteins - genetics | Rats, Sprague-Dawley | Hypoglycemic Agents - pharmacology | Obesity - metabolism | Diabetes Mellitus, Type 2 - blood | Animals | Liraglutide - therapeutic use | Receptors, Gastrointestinal Hormone - genetics | Incretins - therapeutic use | Diabetes Mellitus, Type 2 - drug therapy | Anti-Obesity Agents - pharmacology | Gastric Inhibitory Polypeptide - analogs & derivatives | Glucagon-Like Peptide-1 Receptor - agonists | Type 2 diabetes | Obesity | Control | Glucagon | Rodents | Body weight | Weight loss | Glycosylated hemoglobin | Glucose | Glucose tolerance tests | Dextrose | Diabetes mellitus | Body weight loss | GIP protein | Studies | Glucose tolerance | Weight control | Hemoglobin | Diabetes | Glucagon-like peptide 1 | Long-term effects | Index Medicus
Journal Article
Journal Article
Bone (New York, N.Y.), ISSN 8756-3282, 2016, Volume 91, pp. 102 - 112
Journal Article
American Journal of Physiology - Endocrinology And Metabolism, ISSN 0193-1849, 04/2004, Volume 286, Issue 4, pp. 621 - 625
Journal Article
Diabetologia, ISSN 0012-186X, 3/2016, Volume 59, Issue 3, pp. 533 - 541
Journal Article